FDA Drug-Drug Interaction Database Will Be Functional By 2000, Plan Says
This article was originally published in The Tan Sheet
FDA's drug-drug interaction scientific database will be functional two years ahead of schedule in the Center for Drug Evaluation & Research, according to FDA's revised Prescription Drug User Fee Act information management plan issued Aug. 27.
You may also be interested in...
FDA's Office of Regulatory Affairs will reduce its Prescription Drug User Fee Act II-funded staff by 40 full-time equivalents for each of the remaining two years of the act's authorization period. The plan calls for 10 fewer FTEs in fiscal 1999, and for 40 fewer FTEs in each subsequent year through 2002.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning